David Sholehvar's Insider Trades & SAST Disclosures

David Sholehvar's most recent trade in Invitae Corp was a trade of 850,000 Common Stock done . Disclosure was reported to the exchange on Nov. 13, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Invitae Corp
David B. Sholehvar Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Nov 2023 850,000 850,000 (0%) 0% 0 Common Stock
Neogenomics Inc.
David Sholehvar President, Clinical Services Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 25,826 25,826 - - Stock Option (Right to Buy)
Neogenomics Inc.
David Sholehvar President, Clinical Services Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2022 12,352 43,216 (0%) 0% 0 Common Stock
Neogenomics Inc.
David Sholehvar President, Clinical Services Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 66,372 66,372 - - Stock Option (Right to Buy)
Neogenomics Inc.
David Sholehvar President, Clinical Services Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2022 30,864 30,864 (0%) 0% 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades